Zobrazeno 1 - 10
of 197
pro vyhledávání: '"Wolfgang Ochs"'
The purpose of this volume is to gather the latest experimental results from the H1, ZEUS and HERMES collaborations and to capture new trends in HERA phenomenology. The presentations are by experts for experts, but are suitable for a mixed readership
Autor:
Marlene Stephan, Koray Tascilar, Melek Yalcin-Mutlu, Melanie Hagen, Judith Haschka, Michaela Reiser, Fabian Hartmann, Arnd Kleyer, Axel J. Hueber, Bernhard Manger, Camille Figueiredo, Jayme Fogagnolo Cobra, Hans-Peter Tony, Stephanie Finzel, Stefan Kleinert, Jörg Wendler, Florian Schuch, Monika Ronneberger, Martin Feuchtenberger, Martin Fleck, Karin Manger, Wolfgang Ochs, Matthias Schmitt-Haendle, Hannes Martin Lorenz, Hubert Nüsslein, Rieke Alten, Joerg Henes, Klaus Krüger, Georg Schett, Jürgen Rech
Several studies have shown that tapering or stopping disease-modifying anti-rheumatic drugs (DMARDs) in rheumatoid arthritis (RA) patients in sustained remission is feasible. However, tapering/stopping bears the risk of decline in physical function a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e79a7c7396a3c8c2f2c628d5b58eb29b
https://opus4.kobv.de/opus4-fau/files/23291/jcm-12-03723.pdf
https://opus4.kobv.de/opus4-fau/files/23291/jcm-12-03723.pdf
The proceedings of this workshop gather the latest experimental results from HERA and capture new trends in HERA phenomenology. Although the presentations are by experts, they are suitable for both theoreticians and experimentalists. H1 members also
Autor:
Katinka Albrecht, Katja Thiele, Susanna Späthling, Wolfgang Ochs, Andreas Krause, Johanna Callhoff
Publikováno v:
Arthritis und Rheuma. 42:8-14
ZUSAMMENFASSUNG Hintergrund Angesichts der Zunahme des Anteils älterer Menschen mit rheumatoider Arthritis (RA) gewinnen die spezifischen Anforderungen an ihre medikamentöse Versorgung an Bedeutung. Methodik Mit Daten aus der Kerndokumentation stel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f25a7be75fecbf3c06b28110a5846c06
https://doi.org/10.1055/a-1672-2067
https://doi.org/10.1055/a-1672-2067
Autor:
Klaus Krüger, Martin Feuchtenberger, Monika Ronneberger, H. Nuesslein, David Simon, Koray Tascilar, Axel J. Hueber, Juergen Rech, Hanns-Martin Lorenz, Michaela Reiser, Martin Fleck, Hans-Peter Tony, Rieke Alten, M. Schmitt-Haendle, Camille P. Figueiredo, Joerg Wendler, Wolfgang Ochs, Jayme Fogagnolo Cobra, F. Schuch, K. Manger, Georg Schett, Bernhard Manger, Matthias Englbrecht, Stefan Kleinert, Stephanie Finzel, Melanie Hagen, Joerg Henes, Arnd Kleyer
Publikováno v:
The Lancet Rheumatology. 3:e767-e777
Summary Background Owing to increasing remission rates, the management of patients with rheumatoid arthritis in sustained remission is of growing interest. The Rheumatoid Arthritis in Ongoing Remission (RETRO) study investigated tapering and withdraw
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d0dae4b1e241312843b533b69b20331b
https://doi.org/10.1016/s2665-9913(21)00220-4
https://doi.org/10.1016/s2665-9913(21)00220-4
Osteoporosis in patients with rheumatoid arthritis: trends in the German National Database 2007–2017
Autor:
Lisa Lindner, Johanna Callhoff, Wolfgang Ochs, Angela Zink, Katinka Albrecht, Andreas Krause, Rieke Alten
Publikováno v:
Rheumatology International
Rheumatol Int
Rheumatol Int
Osteoporosis is a frequent comorbidity in rheumatoid arthritis (RA). Due to the improved treatment options for RA, we expect a long-term decrease in osteoporosis as an accompanying disease. Data from the German National Database (NDB) were used to in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eeef72e1c1d4056fb8e1ed81a2ad6331
http://europepmc.org/articles/PMC7591406
http://europepmc.org/articles/PMC7591406
Autor:
C Figuereido, H.-M. Lorenz, L. Valor, Jörg Wendler, M. Schmitt-Haendle, Martin Feuchtenberger, Jörg Henes, Jürgen Rech, Stefan Kleinert, H-P Tony, R. Alten, Martin Fleck, Axel J. Hueber, Stephanie Finzel, Bernhard Manger, Monika Ronneberger, Melanie Hagen, Judith Haschka, A. Kleyer, Michaela Reiser, Georg Schett, Klaus Krueger, Jayme Fogagnolo Cobra, F. Schuch, Wolfgang Ochs, Koray Tascilar, K. Manger
Publikováno v:
Annals of the Rheumatic Diseases. 80:194-195
Background:Due to better treatment strategies and higher remission rates the management of rheumatoid arthritis (RA) patients in sustained remission is of increasing interest (1). The Rheumatoid Arthritis in Ongoing Remission (RETRO) study investigat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::11e0923fd2b90be45380a81c77825eb3
https://doi.org/10.1136/annrheumdis-2021-eular.2174
https://doi.org/10.1136/annrheumdis-2021-eular.2174
Autor:
Melanie Hagen, Wolfgang Ochs, Stefan Kleinert, Jörg Wendler, Michaela Reiser, Jürgen Rech, Jörg Henes, Hubert Nüsslein, Martin Fleck, Hans-Peter Tony, Stephanie Finzel, Bernhard Manger, Axel J. Hueber, Monika Ronneberger, Judith Haschka, Rieke Alten, Camille P. Figueiredo, Klaus Krüger, Jayme Fogagnolo Cobra, F. Schuch, Matthias Englbrecht, Martin Feuchtenberger, Arnd Kleyer, H.-M. Lorenz, K. Manger, Georg Schett
Publikováno v:
The Journal of Rheumatology. 46:460-466
Objective.To analyze the effect of a risk-stratified disease-modifying antirheumatic drug (DMARD)–tapering algorithm based on multibiomarker disease activity (MBDA) score and anticitrullinated protein antibodies (ACPA) on direct treatment costs for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bade26a0d30a106537bd047ce561b9a0
https://doi.org/10.3899/jrheum.180028
https://doi.org/10.3899/jrheum.180028
Autor:
C Figuereido, Jörg Henes, Marlene Stephan, Klaus Krueger, Hans-Peter Tony, Stefan Kleinert, Hanns-Martin Lorenz, Fabian Hartmann, Michaela Reiser, Stephanie Finzel, Karin Manger, Rieke Alten, M. Schmitt-Haendle, Wolfgang Ochs, Martin Feuchtenberger, Arnd Kleyer, Koray Tascilar, Georg Schett, Martin Fleck, Jürgen Rech, H. Nuesslein, Joerg Wendler, Jayme Fogagnolo Cobra, F. Schuch, Axel J. Hueber, Melanie Hagen, Monika Ronneberger, Judith Haschka, Bernhard Manger
Publikováno v:
Poster Presentations.
Background Several studies including our own RETRO study have shown that tapering or stopping disease modifying anti-rheumatic drugs (DMARDs) in rheumatoid arthritis (RA) patients in sustained remission is feasible (1-3). However, tapering/stopping b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d787da89647d7e36151c20ed15212ff5
https://doi.org/10.1136/annrheumdis-2019-eular.3987
https://doi.org/10.1136/annrheumdis-2019-eular.3987
Autor:
Guido Hoese, Katja Thiele, Wolfgang Ochs, Frank Buttgereit, Martin Aringer, Dörte Huscher, Angela Zink, Katinka Albrecht
Publikováno v:
Rheumatology International. 38:569-577
The objective of this study was to evaluate glucocorticoid (GC) use in patients with polymyalgia rheumatica (PMR), giant cell arteritis (GCA) or both diseases (PMR + GCA) under rheumatological care. Data from patients with PMR (n = 1420), GCA (n = 17
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7028338a139f7348a4c2212ff8d081c8
https://doi.org/10.1007/s00296-017-3874-3
https://doi.org/10.1007/s00296-017-3874-3